子宫的小细胞神经内分泌癌:一个病例报告突出了一个罕见的和侵略性的瘤
Nektarios Ntalakos1, Maria Arnaouti1, Evdokia Arkoumani1
1Department of Pathology, Saint Savvas Anticancer Hospital of Athens, Athens, GRC.
Cureus
|September 8, 2025
概括
小细胞神经内分泌宫癌是一种罕见的,攻击性的癌症,通常与HPV有关. 早期诊断和多学科护理,包括化疗,对于改善这种具有挑战性的恶性瘤的结果至关重要.
科学领域:
- 妇科瘤学 妇科瘤学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 宫小细胞神经内分泌癌 (SCNECC) 是一种罕见且具有攻击性的恶性瘤.
- 它经常与高风险的人类乳头瘤病毒 (HPV) 感染有关,并且预后不好.
- SCNECC主要影响40多岁的女性,由于它的稀有性,它带来了诊断和治疗方面的挑战.
研究的目的:
- 报告一名36岁女性的IIB阶段SCNECC病例.
- 突出这一罕见的宫癌的诊断和管理策略.
- 强调为SCNECC提供个性化,多学科的护理的重要性.
主要方法:
- 一个36岁妇女的病例报告,患有高风险的HPV和异常的阴道出血.
- 诊断工作包括镜检查,活检和正子发射断层扫描计算机断层扫描 (PET-CT).
- 治疗包括外部光束放射疗法,支臂疗法和化疗 (cisplatin和etoposide),然后进行间隔手术.
主要成果:
- PET-CT证实了国际妇科和产科联合会 (FIGO) 的IIB阶段SCNECC.
- 多式疗法导致显著的瘤大小减少.
- 间隔手术揭示了残留的神经内分泌癌与广泛的血管入侵,强调瘤的侵略性.
结论:
- 精确的SCNECC诊断需要细致的组织病理学和免疫组织化学评估,以区分它与模仿和转移性疾病.
- 缺乏标准化的治疗方案;因此,个性化,多学科的管理是必不可少的.
- 化学辐射是局部先进的SCNECC的主要支柱,目前正在研究免疫疗法和向药物,以改善患者的治疗结果.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.6K
05:52Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
13.0K
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...